Perspectives on the underlying etiology of HCC and its effects on treatment outcomes
T Ito, MH Nguyen - Journal of Hepatocellular Carcinoma, 2023 - Taylor & Francis
Hepatocellular carcinoma (HCC) continues to be a serious medical problem with poor
prognosis worldwide. The distribution of the major etiologies of HCC is changing due to the …
prognosis worldwide. The distribution of the major etiologies of HCC is changing due to the …
[HTML][HTML] The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy
B Yuan, J Ma, J Wang, J Hao - Frontiers in Endocrinology, 2022 - frontiersin.org
Objective Metformin has attracted more attention from researchers for its newly discovered
antitumor effects. A meta-analysis was performed to reveal the efficacy of metformin on …
antitumor effects. A meta-analysis was performed to reveal the efficacy of metformin on …
[HTML][HTML] Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma
X Cai, S Peng, X Xiao, Z Huang, P Zhang - Scientific Reports, 2024 - nature.com
Clinical research has suggested that chronic HBV infection exerts a certain effect on the
occurrence of cardiovascular disease by regulating cholesterol metabolism in liver cells …
occurrence of cardiovascular disease by regulating cholesterol metabolism in liver cells …
[HTML][HTML] The implications of noncoding rnas in the evolution and progression of nonalcoholic fatty liver disease (Nafld)-related hcc
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver pathology worldwide.
Meanwhile, liver cancer represents the sixth most common malignancy, with hepatocellular …
Meanwhile, liver cancer represents the sixth most common malignancy, with hepatocellular …
[HTML][HTML] Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level
L Wu, Z Li, N Gao, H Deng, Q Zhao, Z Hu, J Chen, Z Lei… - Heliyon, 2024 - cell.com
Background The correlation between metabolic syndrome (MetS) and hepatitis B surface
antigen (HBsAg) loss remains to be further elucidated, particularly in patients receiving …
antigen (HBsAg) loss remains to be further elucidated, particularly in patients receiving …
PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma
J Yi, X Luo, W Huang, W Yang, Y Qi… - Oncology …, 2024 - spandidos-publications.com
Hepatocellular carcinoma (HCC), a common type of liver cancer, is increasing in incidence
worldwide. An early diagnosis of hepatocellular carcinoma (HCC) is still challenging …
worldwide. An early diagnosis of hepatocellular carcinoma (HCC) is still challenging …
Non-Alcoholic Fatty Liver Disease and the Risk of Future Hepatocarcinoma
A Scholten - Science Insights, 2024 - bonoi.org
Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver condition characterized
by excess fat accumulation in the liver in the absence of significant alcohol consumption …
by excess fat accumulation in the liver in the absence of significant alcohol consumption …
[PDF][PDF] División de Estudios de Posgrado e Investigación Facultad de Medicina
SMB Gall - 2023 - ru.dgb.unam.mx
El carcinoma hepatocelular (CHC) es el tumor primario de hígado más frecuente a nivel
mundial, más del 80% de los tumores hepáticos reportados corresponden a esta estirpe …
mundial, más del 80% de los tumores hepáticos reportados corresponden a esta estirpe …